New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Diana Domnitei, Vishal MadaanDepartment of Psychiatry, Creighton University Medical Center, Omaha, NE, USAAbstract: Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for saf...
Guardado en:
Autores principales: | Diana Domnitei, Vishal Madaan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76a7b95d9d09471b84ee133aa3c5f411 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan V, et al.
Publicado: (2013) -
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
por: Weisler RH, et al.
Publicado: (2013) -
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Michael Pennick
Publicado: (2010) -
Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
por: López F, et al.
Publicado: (2011) -
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
por: Ermer J, et al.
Publicado: (2013)